Journey Medical Corporation (DERM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 01:16PM EDT. Market open.
| Previous Close | 3.4000 |
| Open | 3.4000 |
| Bid | 3.4800 x 100 |
| Ask | 3.5800 x 100 |
| Day's Range | 3.3470 - 3.5300 |
| 52 Week Range | 1.0200 - 8.1100 |
| Volume | |
| Avg. Volume | 170,862 |
| Market Cap | 70.361M |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings Date | May 20, 2024 - May 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.83 |
GlobeNewswireJourney Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Pla
GuruFocus.comDirector Justin Smith Acquires 30,000 Shares of Journey Medical Corp (DERM)
Journey Medical Corp (NASDAQ:DERM) has reported an insider purchase according to the latest SEC filings.
Simply Wall St.Journey Medical Full Year 2023 Earnings: EPS Misses Expectations
Journey Medical ( NASDAQ:DERM ) Full Year 2023 Results Key Financial Results Revenue: US$79.2m (up 7.5% from FY 2022...
© 2024 Yahoo. All rights reserved.